文献速递骨质疏松与代谢性骨病关节外科

类风湿关节炎患者骨质疏松的危险因素:一项荟萃分析

Risk factors for osteoporosis in rheumatoid arthritis patients: a meta-analysis.
PubMed 文献 · Osteoporos Int · 2025-11-04

该荟萃分析纳入57篇文献,评估类风湿关节炎患者骨质疏松的危险因素。女性、高龄、既往骨折、绝经状态和糖皮质激素治疗为主要危险因素,较高BMI、充足25-(OH)-D水平及钙和/或维生素D补充为保护因素。吸烟史、饮酒、PTH水平及DMARD治疗与骨质疏松无显著关联。

要点

  • 女性、绝经状态、既往骨折和糖皮质激素治疗是类风湿关节炎患者骨质疏松的主要危险因素。
  • 较高BMI、充足25-(OH)-D水平及钙和/或维生素D补充为保护因素。
  • 吸烟史、饮酒、PTH水平及DMARD治疗与骨质疏松无显著关联。

核心结论

  • 该荟萃分析揭示女性、年龄、绝经状态、既往骨折和糖皮质激素治疗是类风湿关节炎患者骨质疏松的主要危险因素,较高BMI为保护因素,以量化各危险因素的影响并提供个体化预防策略。

研究设计与样本

  • 全面检索PubMed、Embase、Cochrane Library、Web of Science、CNKI、万方、维普及中国生物医学文献数据库,检索时间从建库至2024年12月31日。
  • 使用纽卡斯尔-渥太华量表和医疗保健研究与质量局(AHRQ)评估研究质量。
  • 采用STATA 18计算比值比(OR)及95%置信区间(CI)。
  • 通过漏斗图联合Egger检验评估发表偏倚。
  • 共纳入57篇文献进行荟萃分析。

主要发现

  • 类风湿关节炎患者骨质疏松的显著危险因素包括女性(OR=2.10)、年龄增长(OR=1.11)、既往骨折(OR=2.83)、病程(OR=1.16)和绝经状态(OR=3.96)。
  • 与风险增加相关的实验室和临床参数包括CTX升高(OR=1.01)、DAS28评分较高(OR=1.60)、ESR升高(OR=1.05)、Sharp评分较高(OR=1.12)和RF滴度(OR=1.01)。
  • 糖皮质激素治疗是显著危险因素(OR=2.34)。
  • 保护因素包括较高BMI(OR=0.86)、充足25-(OH)-D水平(OR=0.88)及钙和/或维生素D补充(OR=0.49)。
  • 吸烟史、饮酒、PTH水平或DMARD治疗与类风湿关节炎患者骨质疏松无显著关联。

关键数值与推荐

  • 女性OR=2.10,年龄增长OR=1.11,既往骨折OR=2.83,病程OR=1.16,绝经状态OR=3.96。
  • CTX升高OR=1.01,DAS28评分较高OR=1.60,ESR升高OR=1.05,Sharp评分较高OR=1.12,RF滴度OR=1.01。
  • 糖皮质激素治疗OR=2.34。
  • 较高BMI OR=0.86,充足25-(OH)-D水平OR=0.88,钙和/或维生素D补充OR=0.49。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The purpose of this investigation was to determine risk factors for osteoporosis (OP) in patients with rheumatoid arthritis (RA) through comprehensive literature review and meta-analysis. METHODS: A comprehensive database exploration covered PubMed, Embase, Cochrane Library, Web of Science, CNKI, Wanfang, VIP, and Chinese Biomedical databases from inception to December 31, 2024. Study quality was assessed using the Newcastle-Ottawa Scale for Healthcare Research and Quality (AHRQ). Data analyses involved STATA 18 to calculate odds ratios (ORs) with 95% confidence intervals (CIs). Publication bias assessment involved funnel plots in conjunction with Egger's test. RESULTS: Fifty-seven articles were incorporated in the meta-analysis. Significant risk factors for OP in RA patients included female (OR = 2.10), advancing age (OR = 1.11), prior fracture (OR = 2.83), disease duration (OR = 1.16), and postmenopausal status (OR = 3.96). Laboratory and clinical parameters that correlated with increased risk included elevated CTX (OR = 1.01), higher DAS28 scores (OR = 1.60), increased ESR (OR = 1.05), higher Sharp Scores (OR = 1.12), and RF titers (OR = 1.01). Glucocorticoid therapy constituted a significant risk factor (OR = 2.34). Protective factors included higher BMI (OR = 0.86), adequate 25-(OH)-D levels (OR = 0.88), and calcium and/or vitamin D supplementation (OR = 0.49). No significant associations were found between OP in individuals with RA and smoking history, alcohol consumption, PTH levels, or DMARD therapy. This meta-analysis systematically identified risk factors for OP among individuals with RA. Female, advanced age, prior fracture, longer disease duration, postmenopausal status, CRP, ESR, CTX, RF titers, DAS28, Sharp Score, and glucocorticoid therapy increased OP risk. Conversely, higher BMI, adequate 25-(OH)-D status, and calcium/vitamin D supplementation demonstrated protective effects. CONCLUSION: This meta-analysis reveals female, age, postmenopausal status, prior fracture, and glucocorticoid therapy as major risk factors for osteoporosis in rheumatoid arthritis, with higher BMI as protective factors to quantify the impact of each risk factor and provide strategies for individualized prevention.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Fu T, Zhang R, Yue L, et al. Risk factors for osteoporosis in rheumatoid arthritis patients: a meta-analysis. Osteoporos Int. 2025. PMID: 41188646. doi:10.1007/s00198-025-07700-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。